Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

EP Biocomposites Ltd - 543595 - Voluntary Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 Dear Sir/Madam, Pursuant to the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to voluntarily intimate you that an additional acquisition of 4000 (four thousand only) equity shares of the Company at an average price of INR 203/- (Rupees Two Hundred and Three Only) was made by Mr. Rajkumar G. Kamat, Promoter and Managing Director of the Company, on January 09th, 2023. The same is being disclosed voluntarily to ensure good governance practice. The acquisition is fully compliant with all the applicable legislations and regulations and is reflective of the confidence of the Management on the course taken by the Company. The number of shares shall be updated in the next filing of the shareholding pattern of the Company. You are hereby requested to take the same on record. Thanking you, Yours faithfully, For EP Biocomposites Limited Akshada Neugui Company Secretary & Compliance Officer
10-02-2023
Bigul

EP Biocomposites Ltd - 543595 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 To, Bombay Stock Exchange Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai - 400 001 Central Depository Services (India) Limited Marathon Futurex, Lower Parel, Mumbai - 400 013 National Securities Depository Limited Kamala Mills Compound, Lower Parel, Mumbai - 400 013 SUB: Covering letter for Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on December 31, 2022 Dear Sir/Madam, In relation to above mentioned caption, please find enclosed herewith Certificate from Bigshare Services Private Limited, in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on December 31, 2022. Please take the above information on record. Thanking you, Yours faithfully, For EP Biocomposites Limited CS Akshada Neugui Company Secretary & Compliance Officer
09-01-2023
Bigul

EP Biocomposites Ltd - 543595 - Outcome Of Board Meeting Dated, 12.11.2022 For Adoption Of Unaudited Financial Results For Half Year Ended September 30, 2022

 Dear Sir/Madam, Sub: Outcome of Board Meeting & Submission of Unaudited Financial Results for Half-Year ended September 30,2022 In continuation of our intimation dated November 05, 2022 pursuant to regulation 33 read with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Unaudited Financial Results for the Half Year ended September 30, 2022 duly approved by the Board of Directors of the Company in their meeting held today i.e. November 12, 2022 together with Statement of Assets and Liabilities and Limited Review Report thereon are enclosed herewith. The Board Meeting commenced at 04.10 P.M. and concluded at 04.30 P.M. The aforesaid results are also being disseminated on Company's website at www.epbiocomposites.com You are hereby requested to kindly take the above information on record. Thanking You. Yours faithfully, FOR EP BIOCOMPOSITES LIMITED Akshada Neugui Company Secretary and Compliance Officer
12-11-2022
Bigul

EP Biocomposites Ltd - 543595 - Board Meeting Intimation for Adoption Of Unaudited Financial Results For Quarter Ended September 30, 2022

 EP Biocomposites Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 ,inter alia, to consider and approve ITEM NO. 1: To elect the Chairperson of the Meeting. ITEM NO. 2: To ascertain quorum for the meeting and grant leave of absence. ITEM NO. 3: To note and take on record the minutes of the 19th Board Meeting held on Monday, 03rd day of October, 2022. ITEM NO. 4: To note and take on record Resolution(s) passed through circulation. ITEM NO. 5: To consider and approve Un-audited Financial Results of the Company with limited review report for half-year ended September 30, 2022. ITEM NO. 6: To transact any other business with the permission of the Chair.
05-11-2022
Bigul

EP Biocomposites Ltd - 543595 - Statement Of Investor Complaints For The Quarter Ended September 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- AKSHADA NEUGUIDesignation :- Company Secretary and Compliance Officer
18-10-2022
Bigul

EP Biocomposites Ltd - 543595 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Sub: Covering letter for Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on September 30, 2022 Dear Sir, In relation to above mentioned caption, please find enclosed herewith Certificate from Bigshare Services Private Limited, in compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on September 30, 2022. Please take the above information on record. Thanking You, Yours Faithfully For EP Biocomposites Limited CS Akshada Neugui Company Secretary & Compliance Officer
15-10-2022
Bigul

EP Biocomposites Ltd - 543595 - Appointment of Company Secretary and Compliance Officer

 Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we wish to inform you that Board of Directors of the Company in its meeting held on Monday, October 03, 2022 has approved the appointment of Mrs. Akshada Neugui (Membership No. A67028), as a Company Secretary and a Compliance Officer of the Company with effect from the closure of the business hours of October 03, 2022. She is being appointed as a Company Secretary and a Compliance Officer to discharge the obligations prescribed under the Companies Act, 2013 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The details required under Regulation 30 of the Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015, dated September 09, 2015 are enclosed as Annexure I. We request you to take the same on record. Thanking you, Yours faithfully, For EP Biocomposites Limited Rajkumar Kamat Managing Director
04-10-2022
Bigul

EP Biocomposites Ltd - 543595 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

 Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we wish to inform that Mr. Mohammad Faiyazul Haq (Membership No. A52141), Company Secretary and Compliance Officer of the Company tendered his resignation which is accepted with effect from the closure of the business hours of October 03, 2022. His successor shall be appointed in due course, within the time limit prescribed under the provisions of the Companies Act, 2013 and Rules made thereunder read with the applicable provisions of the Listing Regulations and the same shall be duly intimated to the Stock Exchange. The details required under Regulation 30 of the Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015, dated September 09, 2015 are enclosed as Annexure I. The letter of resignation is attached as Annexure II. We request you to take the same on record. Thanking you Yours faithfully, For EP Biocomposites Limited Rajkumar Kamat Managing Director
04-10-2022
Bigul

EP Biocomposites Ltd - 543595 - Closure of Trading Window

 Dear Sir/Madam, Sub: Trading window closure intimation This is to inform you that the Company has closed the trading window for the earnings release of the half year ending September 30, 2022 in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, from September 30, 2022. The trading window will re-open after 48 hours of dissemination of the financial results of the Company. This is for your information and records. This will also be hosted on the Company's website, at https://epbiocomposites.com/ Yours sincerely, For EP Biocomposites Limited Rajkumar Kamat Managing Director
03-10-2022
Bigul

EP Biocomposites Ltd - 543595 - Listing of equity shares of EP Biocomposites Ltd

 Trading Members of the Exchange are hereby informed that effective from September 13, 2022, the equity shares of EP Biocomposites Ltd (Scrip Code: 543595) are listed and admitted to dealings on the Exchange in the list of ''MT'' Group Securities. For further details please refer to the notice no 20220912-21 dated September 12, 2022.
13-09-2022
Close

Let's Open Free Demat Account